TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3029% below fair value
$91.38−0.62 (-0.67%)
Close on Nov 13, 2026Market cap $3.17BP/E 25.0Yield 0.00%
TransMedics operating margin
Operating margin is operating income as a percentage of revenue.
TransMedics's operating margin for the twelve months ending Sep 30, 2026 was 11.9%. For fiscal 2025 it was 17.9%, against 8.5% the year before. The highest annual figure on record is 17.9% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.9% | +9.4 |
| FY2024 | Dec 31, 2024 | 8.5% | +20.4 |
| FY2023 | Dec 31, 2023 | -11.9% | +21.7 |
| FY2022 | Dec 31, 2022 | -33.6% | +96.7 |
| FY2021 | Dec 31, 2021 | -130.3% | −27.4 |
| FY2020 | Dec 31, 2020 | -102.9% | +22.5 |
| FY2019 | Dec 28, 2019 | -125.4% | +30.1 |
| FY2018 | Dec 29, 2018 | -155.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 13.9% | −2.3 |
| Q2 FY2026 | Jun 30, 2026 | 12.5% | −10.7 |
| Q1 FY2026 | Mar 31, 2026 | 7.6% | −11.5 |
| Q4 FY2025 | Dec 31, 2025 | 13.2% | +6.1 |
| Q3 FY2025 | Sep 30, 2025 | 16.2% | +12.6 |
| Q2 FY2025 | Jun 30, 2025 | 23.2% | +12.3 |
| Q1 FY2025 | Mar 31, 2025 | 19.1% | +6.3 |
| Q4 FY2024 | Dec 31, 2024 | 7.1% | +3.9 |
| Q3 FY2024 | Sep 30, 2024 | 3.6% | +46.3 |
| Q2 FY2024 | Jun 30, 2024 | 10.9% | +12.7 |
| Q1 FY2024 | Mar 31, 2024 | 12.8% | +17.9 |
| Q4 FY2023 | Dec 31, 2023 | 3.2% | +24.8 |
| Q3 FY2023 | Sep 30, 2023 | -42.7% | −21.1 |
| Q2 FY2023 | Jun 30, 2023 | -1.7% | +45.8 |
| Q1 FY2023 | Mar 31, 2023 | -5.0% | +54.0 |
| Q4 FY2022 | Dec 31, 2022 | -21.6% | +95.6 |
| Q3 FY2022 | Sep 30, 2022 | -21.6% | +196.8 |
| Q2 FY2022 | Jun 30, 2022 | -47.5% | +73.3 |
| Q1 FY2022 | Mar 31, 2022 | -59.0% | +33.3 |
| Q4 FY2021 | Dec 31, 2021 | -117.2% | −39.9 |
| Q3 FY2021 | Sep 30, 2021 | -218.3% | −153.3 |
| Q2 FY2021 | Jun 30, 2021 | -120.8% | +111.1 |
| Q1 FY2021 | Mar 31, 2021 | -92.3% | +14.2 |
| Q4 FY2020 | Dec 31, 2020 | -77.3% | +66.2 |
| Q3 FY2020 | Sep 30, 2020 | -65.0% | +35.5 |
| Q2 FY2020 | Jun 30, 2020 | -231.8% | −95.8 |
| Q1 FY2020 | Mar 31, 2020 | -106.5% | +21.0 |
| Q4 FY2019 | Dec 28, 2019 | -143.5% | +36.0 |
| Q3 FY2019 | Sep 28, 2019 | -100.5% | −3.0 |
| Q2 FY2019 | Jun 29, 2019 | -136.0% | +40.9 |
| Q1 FY2019 | Mar 30, 2019 | -127.5% | +62.3 |
| Q4 FY2018 | Dec 29, 2018 | -179.5% | – |
| Q3 FY2018 | Sep 29, 2018 | -97.5% | – |
| Q2 FY2018 | Jun 30, 2018 | -176.9% | – |
| Q1 FY2018 | Mar 31, 2018 | -189.8% | – |
See a number that looks wrong?